In reflecting on the political and policy pressures they faced from their respective presidential administrations, a panel of former US FDA commissioners opined that the agency would fare best if it were afforded a greater degree of independence.
Speaking at an Oct. 19 meeting hosted by the Food and Drug Law Institute (FDLI), Robert Califf, the predecessor to...






